At a glance
- Vasu Healthcare and Peakfinity Labs deployed Formulaite's R&D Agent as FormuCore.
- FormuCore is a CDMO formulation decision engine for Vasu's in-house team.
- FormuCore helps the team generate clinically-backed formulation rationale, dosage-form reasoning, and client-ready technical support.
- The reported results were a 30% reduction in formulation cycle time, 55% reduction in sales closing time, and 4x lift in inbound formulation leads.
The challenge
For a CDMO, formulation velocity and sales confidence are tied together. Formulators need to deliver more client formulations without losing scientific quality, while sales teams need credible technical rationale early enough to shorten the closing cycle.
Vasu Healthcare brought a 45-year phyto-pharmaceutical base, WHO GMP manufacturing, a DSIR-certified Vasu Research Centre, and a 200+ product portfolio. The modernization opportunity was to put a clinically-backed decision engine inside that existing R&D system without replacing the formulation team.
How Formulaite worked with Vasu and Peakfinity
Formulaite's R&D Agent was deployed as FormuCore inside Vasu Healthcare and Peakfinity Labs. Vasu's formulators still lead the work; FormuCore accelerates evidence gathering, active selection, dosage form reasoning, clinical rationale generation, and client-facing explanation.
FormuCore gives the team a faster way to attach clinical rationale, formulation logic, and technical explanation before a proposal reaches a prospect or a formulation reaches manufacturing.
Product examples from the FormuCore surface
The FormuCore deployment also supports the client-facing formulation surface that Peakfinity can show to brands, including product concepts and private-label formulation opportunities backed by a stronger technical story.
Why it mattered
The impact compounds across the CDMO funnel. A 30% formulation cycle time reduction means more client formulations delivered per formulator per month. A 55% sales closing time reduction means prospects move faster when technical rationale is credible earlier. A 4x lift in inbound formulation leads reflects the market response to a formulation practice that can sell clinically-backed formulation as its default output.
For Peakfinity Labs, FormuCore becomes a durable client-facing differentiation layer. For Vasu Healthcare, it carries an established phyto-pharmaceutical R&D organization into a more AI-assisted formulation operating model.
What to know
The reported operating metrics come from Vasu Healthcare and Peakfinity Labs' FormuCore deployment, where the platform was embedded into an existing formulation, R&D, and commercial workflow.